Related Experiment Video
Updated: Jul 15, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Overcoming HIV-1 resistance to RNA interference
Daniel Boden1, Oliver Pusch, Bharat Ramratnam
1Aaron Diamond AIDS Research Center, NY, NY, USA.
Summary
RNA interference (RNAi) offers potential for HIV-1 genetic therapy by degrading viral RNA. However, rapid HIV-1 mutation emergence presents a significant challenge to durable virus suppression using RNAi strategies.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Background:
- RNA interference (RNAi) is a mechanism for sequence-specific RNA degradation.
- Short interfering RNA (siRNA) delivery via vectors enables gene silencing in human cells.
- RNAi has shown promise in reducing human immunodeficiency virus type 1 (HIV-1) replication by targeting viral and host factors.
Purpose of the Study:
- To review recent advancements in RNAi-based strategies against HIV-1.
- To explore the potential of RNAi as a genetic therapy for HIV-1 infection.
- To identify challenges and potential solutions for overcoming HIV-1 resistance to RNAi.
Main Methods:
- Review of existing literature on RNAi applications for HIV-1.
- Analysis of siRNA targeting strategies against viral (tat, gag, rev) and host (CCR5, CD4) genes.
- Evaluation of HIV-1 replication kinetics and resistance mechanisms.
Main Results:
- RNAi can effectively decrease HIV-1 replication in lymphocytic cells.
- Rapid emergence of HIV-1 mutants resistant to siRNA is a major obstacle.
- Dynamic replication kinetics of HIV-1 contribute to treatment challenges.
Conclusions:
- RNAi holds therapeutic potential for HIV-1, but resistance is a significant hurdle.
- Further research is needed to develop strategies that overcome HIV-1 RNAi resistance.
- Combination approaches may be necessary for durable HIV-1 suppression using RNAi.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...